We have identified one cell‐based substrate of HtrA2, vimentin; future studies are warranted to determine whether the HtrA2‐vimentin axis is relevant to other models of senescence in cancer cells, and how it may be relevant to primary cells, which do not normally express vimentin, but may induce its expression during senescence. The gene discussed is VIM; the disease is cancer.